L26/P-652 Spindle-induced pronuclear splitting as possible origin of diploid 2.1 zygotes and third-pronucleus size as a predictor of developmental competence
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Escriba und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does mechanical disturbance of meiotic spindle during ICSI contribute to the formation of 2.1 zygotes and impair their developmental competence depending on third pronucleus size? Summary answer 2.1 zygotes likely originate from partial splitting of pronucleus (PN) membrane after spindle disruption, and their blastocyst development decreases progressively with increasing third-PN size. What is known already 3PN zygotes are typically excluded as triploid, but previous work showed that the size of the third pronucleus strongly predicts genetic outcome. “2.1” zygotes—two normal pronuclei plus a smaller third—are diploid in ∼90% of cases, compared with only 4% in same-size (SS) 3PNs. Despite diploidy, 2.1 embryos display reduced blastocyst rates (BR) versus 2PN embryos. Early explanations invoked embryonic self-correction, but recent hypotheses propose that transient spindle disturbance during ICSI may split chromatin into two clusters, generating an apparent extra PN without extra genome. Proof of this, and whether PN size reflects damage severity or predicts development has never been reported. Study design, size, duration One prospective observational study to proof origin hypothesis (January–October 2025) was set at a private IVF centre. Incidences of 2.1 and SS zygotes after polarized light (PL)-guided ICSI with spindle visualization (n = 573 oocytes) were compared versus a conventional-ICSI cohort (n = 750 oocytes) meeting identical inclusion criteria. In parallel, another prospective analysis of 93 2.1 embryos with genetic and developmental outcomes evaluated associations between third pronucleus size and blastocyst formation. Sibling 2PN embryos served as internal controls. Participants/materials, setting, methods PL-ICSI was performed avoiding spindle–needle contact. PL-ICSI cases included ≤3 mature oocytes from women <45 years, excluding male factor, vitrified oocytes and monogenic testing cycles. Fertilisation and 3PN subtype rates were recorded prospectively. For the developmental analysis of 2.1 embryos, as the idea is that one single PN splits into 2, absolute PN diameters, differences between large and medium PNs, and the PN-size ratio (small/medium) were calculated. Outcomes were compared using chi-square and parametric tests. Main results and the role of chance Fertilisation rates were comparable between PL-ICSI and conventional ICSI (77.1% vs 78.3%, p = 0.640). PL-ICSI did not reduce, the incidence of SS zygotes (3.5% vs 1.9%, p = 0.064). In contrast, 2.1 zygotes were less frequent after PL-ICSI (0.5% vs 1.6%) suggesting a possible protective effect, although this trend did not reach significance (p = 0.067; Fisher=0.072). In the developmental cohort, 38/93 2.1 embryos formed blastocysts, all confirmed euploid. Third-PN size parameters were strongly associated with development. Small-PN diameter correlated with the PN-difference value (r = 0.21, p=.046). Blastocyst-forming embryos showed smaller small-PN diameters (10.37±3.26 µm vs 12.35±3.16 µm; t(91)=2.93, p=.002), lower small/medium PN ratios (44.08%±14.8 vs 56.16%±17.94; t(91)=3.42, p<.001), and reduced M-S PNs-difference values (2.0±1.8 µm vs 3.22±3.33 µm; t(86.7)=2.27, p=.013)versus the ones that did not reach. Point-biserial correlations confirmed negative associations between blastocyst formation and the small/medium PN ratio (rpb = −0.34, p=.001), small-PN size (rpb = −0.29, p=.004), and M-S PNs-difference (rpb = −0.21, p=.043). Sibling 2PN blastocyst rates did not differ across PN-size categories (r = 0.06, p=.584), indicating the absence of patient-specific effects. Overall, PL-ICSI did not modify SS occurrence and showed only a non-significant reduction in 2.1 zygotes. In 2.1 embryos, smaller third-PN size metrics were consistently associated with improved blastocyst development, suggesting a size-dependent effect of early nuclear injury. Limitations, reasons for caution The incidence of 2.1 zygotes is low; therefore, PL-ICSI data are currently underpowered to detect significant differences and larger sample sizes are required to determine its effect on 2.1 prevention. Biological confirmation of pronuclear splitting mechanisms requires live-imaging or chromatin-tracking studies. Further multicenter data are required to validate the dose–response observations. Wider implications of the findings Our findings support that 2.1 zygotes represent diploid embryos arising from partial structural disruption of a single pronucleus, rather than true abnormal fertilization. PN-size metrics may help identify diploid embryos with developmental potential and refine embryo exclusion criteria, potentially reducing unnecessary loss of viable embryos. Trial registration number No
Zitieren
APA
Escriba, M., Gonzalez, D., Benavent, M., Aibar, J., Lopez, V., Miret, C., Crespo, J., & Teruel, J. (2026). L26/P-652 Spindle-induced pronuclear splitting as possible origin of diploid 2.1 zygotes and third-pronucleus size as a predictor of developmental competence. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.982
Vancouver
Escriba M, Gonzalez D, Benavent M, Aibar J, Lopez V, Miret C, et al. L26/P-652 Spindle-induced pronuclear splitting as possible origin of diploid 2.1 zygotes and third-pronucleus size as a predictor of developmental competence. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.982
BibTeX
@article{Escriba2026,
author = {Escriba, M. and Gonzalez, D. and Benavent, M. and Aibar, J. and Lopez, V. and Miret, C. and Crespo, J. and Teruel, J.},
title = {L26/P-652 Spindle-induced pronuclear splitting as possible origin of diploid 2.1 zygotes and third-pronucleus size as a predictor of developmental competence},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.982}
}
EUVIMED